Gene · 3623
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of Cyanobacterial Harmful Algal Bloom Toxin Microcystin-LR on Gonadotropin-Dependent Ovarian Follicle Maturation and Ovulation in Mice. | Environ Health Perspect | 2023 | 37342990 | PubTator, text mining | PubMed |
| Evaluation of Antituberculosis Activity and in Silico Properties of Oxymethylene-cyclo-1,3-diones. | Chem Biodivers | 2023 | 37306664 | PubTator, text mining | PubMed |
| Tuberculosis of the spine. | World J Orthop | 2023 | 37304201 | PubTator, text mining | PubMed |
| Microbiological Investigations of Fine Needle Aspirates from Newly Suspected and Previously Treated Tubercular Lymphadenitis Patients. | Infect Drug Resist | 2023 | 37283940 | PubTator, text mining | PubMed |
| Transmission and resistome of extremely drug-resistant tuberculosis in Beijing, China: A retrospective population-based epidemiological study. | J Infect Public Health | 2023 | 37271100 | PubTator, text mining | PubMed |
| Association of Polymorphisms in FSHR, INHA, ESR1, and BMP15 with Recurrent Implantation Failure. | Biomedicines | 2023 | 37239044 | PubTator, text mining | PubMed |
| Maternal pre-conceptional glyphosate exposure impacts the offspring hepatic and ovarian proteome. | Toxicol Sci | 2023 | 37208198 | PubTator, text mining | PubMed |
| Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India. | Indian J Med Res | 2023 | 37202936 | PubTator, text mining | PubMed |
| Profile and Frequency of Mutations Conferring Drug-Resistant Tuberculosis in the Central, Southeastern and Eastern Ethiopia. | Infect Drug Resist | 2023 | 37201127 | PubTator, text mining | PubMed |
| Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment. | Infect Drug Resist | 2023 | 37193296 | PubTator, text mining | PubMed |
| Nuclear Receptor Gene Variants Underlying Disorders/Differences of Sex Development through Abnormal Testicular Development. | Biomolecules | 2023 | 37189438 | PubTator, text mining | PubMed |
| Extracellular matrix-derived scaffolds in constructing artificial ovaries for ovarian failure: a systematic methodological review. | Hum Reprod Open | 2023 | 37180603 | PubTator, text mining | PubMed |
| SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model. | Sci Signal | 2023 | 37159520 | PubTator, text mining | PubMed |
| Molecular Characterization of katG and inhA Mutations by Genotype MTBDRplus Line Probe Assay To Guide Isoniazid and Ethionamide Use for Drug-Resistant Tuberculosis. | Cureus | 2023 | 37153291 | PubTator, text mining | PubMed |
| Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity. | Front Genet | 2023 | 37152993 | PubTator, text mining | PubMed |
| Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach. | Adv Appl Bioinform Chem | 2023 | 37143606 | PubTator, text mining | PubMed |
| Placental transcriptome analysis of hypertensive pregnancies identifies distinct gene expression profiles of preeclampsia superimposed on chronic hypertension. | BMC Med Genomics | 2023 | 37131171 | PubTator, text mining | PubMed |
| Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies. | Expert Rev Anti Infect Ther | 2023 | 37128947 | PubTator, text mining | PubMed |
| Effectiveness of Xpert MTB/RIF and the Line Probe Assay tests for the rapid detection of drug-resistant tuberculosis in the Central African Republic. | PLOS Glob Public Health | 2023 | 37126485 | PubTator, text mining | PubMed |
| At Long Last: Short, All-Oral Regimens for Multidrug-Resistant Tuberculosis in the United States. | Open Forum Infect Dis | 2023 | 37125228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3623/papers?page=9